Navigation Links
Pediatric Cancer Stem Cell Identified

Dr. Leonard Zon (Childrens Hospital Boston) and colleagues have identified the cancer stem cell for rhabdomyosarcoma, the most common soft-tissue sarcoma of childhood.

'Identifying the cancer stem cell and the evolutionarily conserved genetic programs underlying self-renewal in ERMS will likely lead to new insights into how to destroy these cell types in established malignancies,' explains Dr. Zon.

Rhabdomyosarcoma (RMS) is an aggressive cancer that arises from a primitive skeletal muscle cell called a "rhabdomyoblast". Depending upon on the histology of the cancerous cells, there are several different subtypes of RMS. Embryonal rhabdomyosarcoma (ERMS) is the most common subtype, usually found in children under 15, in the head and neck region and genitourinary tract.

Dr. Zon and colleagues have developed an animal model to identify and test therapeutic targets of human ERMS. The scientists artificially activated the RAS pathways to induce ERMS in a strain of genetically engineered zebrafish. Some transgenic zebrafish developed visible tumors by 10 days of age.

Through their model, Dr. Zon and colleagues were able to identify both an ERMS tumor-cell-of-origin and a novel genetic signature that underlies ERMS progression in zebrafish and human patients. Cancer stem cells make up only a small fraction of the overall number of cells in a tumor. However, they are capable of giving rise to other cancer cells, and thereby drive tumor growth and metastasis. To prevent recurrence and progression, effective long-term therapies must target the self-renewing population of cancer stem cells.

The zebrafish is ideally suited for use in targeted chemical genetic approaches to specifically inactivate cancer pathways we have identified in our study. Identifying drugs that inactivate these pathways in the ERMS cancer stem cell may have far reaching implications for treatment of patients with this disease.
<
'"/>




Page: 1 2

Related medicine news :

1. Support Services found to Dramatically Impact Pediatric Health Care
2. Pediatricians differ in their opinion of child abuse
3. New Treatment Discovered For Pediatric Cholera
4. Pediatricians Need To Talk To Parents Of Overweight Kids
5. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
6. FDA Accords Priority Review For Pediatric Crohns Disease Drug
7. WHO Updates Outdated Pediatric Growth Charts
8. Pediatricians Resignations Cause Concern at Sale
9. Mental Health Providers Can Be Successfully Located With Pediatricians
10. World’s First Pediatric Laparoscopic Liver Surger
11. Pediatric Dental Care Found Wanting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pediatric Cancer Stem Cell Identified

(Date:7/25/2008)...liance to be presented at Fenway Park ...y 25 /PRNewswire/ -- CVS/pharmacy announced today,...4 million in just 21 days,through its annual in-st...,the seventh year of the annual fundraising effort...for ALS research. This year,s fundraiser took,plac...
(Date:7/25/2008)...gus can cause immune system changes , , ...ence linking gastroesophageal reflux disease (GERD...y Medical Center researchers. , An association ...1970s, and since then studies have shown that betw...lso experience GERD symptoms. But the actual link ...
(Date:7/25/2008)...am delivers immediate cost savings for http://www...to language interpreters] to firms switching lang... , Washington, D.C. (Vocu...nc.com/index.html [(Language Learning Enterprises...anslation, and language instruction services to th...
(Date:7/25/2008)...ou are an Olympian, Professional Athlete, Elite Am...u Need to Know about Hydration to Boost Sports Per...r , Marina del Rey, Calif...tes are heading to Beijing following years of inte...pes of capturing an Olympic medal and securing the...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
... that she feared that her recent miscarriage was g...he 25-year-old, who lost her baby when she was thr...coping with bad times since the beginning of this ...ould never recover after losing the baby. "After ...
...man's performance in the bedroom, but as researche... function . This finding means that the popular d...ially save the lives of people with specific heart...was conducted by researchers at the University of ...
...l of Medicine in St. Louis have developed the firs... hoping it will help explain why the success of th...organ transplants. Ultimately, the mouse model co...therapies to prevent lung transplant rejection a ...
...as admitted that she fears that an innocent kiss w...ner said that she has major trust issues, and that...e of it, for it is a waste of her time and kisses....e is also scared of ending up having 'mouth herpes...
Other Medicine News:Health News:Viagra Improves Heart Function, Finds Study 2Health News:Viagra Improves Heart Function, Finds Study 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 2Health News:Researchers Develop First Mouse Model of Lung Transplantation 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 4
(Date:7/22/2008)...er 293-patient European, trial -, http://www.cr... MONTREAL, July 22 / CryoCa...therapy products to treat cardiac,arrhythmias, tod...m three,European study centers using the Company,s...lier today in the Journal of the American College ...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
(Date:7/22/2008)...of Treating Patients with ...SI, South Korea, July 22 /-,Jennerex,... its South,Korean partner Green Cross Corp., annou...ical trial of its first-in-class lead product JX-5...d and resulted in clear,anti-cancer efficacy in pa...
(Date:7/22/2008)...R) Resulted in Significant, Reductions in A1C in P...hm Used, BRIDGEW...he "Adjust to,Target in Type 2 Diabetes: Compariso...or Adjustment of Mealtime Insulin Glulisine" study...ion,s (ADA) medical journal,Diabetes Care. This s...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Administration Anesthetized to Ailments of Nations Children 4103 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 2Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 3Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 4Coherent Inc to Webcast Fourth Fiscal Quarter 2007 Results 1355 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 2
...tion in Intestinal Adenomas Suggesting,Possible Be...,Cancer, EL DORADO HILLS, Calif., March 07, 2007 /...s of a study on the effect of rice bran,on the num...ished,in the January 9, 2007 online edition of the...t the Department of Cancer Studies and,Molecular M...
...of Higher Doses to Further Reduce Antibodies,to Do...wswire-FirstCall/ -- La Jolla,Pharmaceutical Compa...ts from its ongoing double-blind, placebo-controll...s sodium), its drug,candidate for systemic lupus e...im antibody data indicate that patients treated,wi...
Other Medicine Technology:British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7
The NOW® Malaria Test is a field or laboratory test for the differential diagnosis of a Malaria infection. It is intended for the detection of circulating Plasmodium falciparum (P.f.) antigen
Ultraview 1700 Central Monitor
...tient Care Monitor (PCM) and Central Station provi...PCM extends the cardiac cath or electrophysiology ...ath and/or EP procedures, providing both physiomon...device either standalone or on its own network. W...
...nitoring via the Acuity central station and Welch ...nvert non-monitored beds into centrally monitored ...t both wireless and hardwired monitors and clinica...ities from a community hospital to a teaching inst...
Medicine Products: